Pro Medicus Secures $33M Contract with University of Kentucky

Key Highlights

• Pro Medicus (ASX: PME) signs a $33M, 9-year deal to implement Visage 7 platform at the University of Kentucky.
• The project includes a full-stack solution: Visage 7 Viewer, Workflow, and Open Archive modules.
• Strengthens Pro Medicus’ (ASX: PME) position in the North American healthcare IT market.

Pro Medicus Expands North American Presence with Major Academic Partnership

Pro Medicus Limited (ASX: PME), a global leader in healthcare imaging technology, has solidified its presence in the North American market by securing a $33M, 9-year contract with the University of Kentucky (UK). This deal highlights the company’s growing influence in the healthcare sector, particularly among academic medical institutions.

The contract, facilitated through its U.S. subsidiary Visage Imaging, underscores the transition from traditional imaging solutions to Pro Medicus’ (ASX: PME) cloud-based enterprise imaging platform. This transformative initiative will provide UK HealthCare, a leading academic health system, with enhanced imaging capabilities across its network of hospitals and clinics.

The Visage 7 Platform: A Comprehensive Solution

The agreement involves the implementation of Pro Medicus’ (ASX: PME) full-stack solution, including:

• Visage 7 Viewer: An ultra-fast, clinically advanced diagnostic imaging tool.
• Visage 7 Open Archive: A scalable and efficient archive for seamless integration.
• Visage 7 Workflow: An enterprise-wide workflow solution designed to optimize operations.

By adopting this technology, the University of Kentucky aims to replace its legacy PACS (Picture Archiving and Communication System) and vendor-neutral archive systems. The integration will extend across the healthcare system, ensuring efficient enterprise distribution of images and compatibility with the university’s electronic health record (EHR) system.

A Cloud-First Strategy for Enhanced Efficiency

One of the standout features of the Visage 7 platform is its cloud-first architecture. As the adoption of cloud technologies accelerates within healthcare, Pro Medicus (ASX: PME) has positioned itself as a leader in this domain. The company’s CloudPACS strategy is particularly suited to academic institutions like the University of Kentucky, which require scalability, speed, and seamless integration for research and clinical applications.

According to Pro Medicus (ASX: PME) CEO Dr. Sam Hupert, “Our full-stack solution offers unparalleled speed and functionality. The University of Kentucky is the latest academic institution to recognize the benefits of our cloud-based imaging platform. This trend reinforces the value of our CloudPACS strategy in meeting the evolving needs of the healthcare IT market.”

Strategic Significance for Pro Medicus

This deal is part of a series of recent successes for Pro Medicus (ASX: PME) in North America. Other notable contracts include a $330M agreement with Trinity Health and a $30M contract with Duly Health and Care. These deals underscore the company’s ability to secure long-term partnerships with leading healthcare providers, cementing its reputation for innovation and reliability.

In the highly competitive healthcare IT sector, Pro Medicus’ (ASX: PME) focus on academic and research institutions provides a strategic advantage. The University of Kentucky partnership not only adds to its growing portfolio but also sets a benchmark for future collaborations.

Implications for the Healthcare Sector

The adoption of the Visage 7 platform by the University of Kentucky represents a broader shift in the healthcare industry toward integrated, cloud-based solutions. This trend is driven by the need for faster diagnostics, improved data accessibility, and enhanced operational efficiency.

For academic health systems, the benefits extend beyond clinical care. The platform’s scalability and advanced capabilities make it an ideal choice for institutions engaged in cutting-edge research and medical education.

Financial and Market Impact

Pro Medicus(ASX: PME)  continues to deliver exceptional returns for its shareholders. The company’s share price has seen a remarkable 163.33% increase over the past year, reflecting its strong financial performance and strategic growth initiatives.

With a market capitalization of $26.44B, Pro Medicus (ASX: PME) ranks among the top companies on the ASX, reinforcing its position as a leader in healthcare technology.

What’s Next?

Pro Medicus’ (ASX: PME) partnership with the University of Kentucky is a testament to its leadership in healthcare imaging technology. By providing cutting-edge, cloud-based solutions, the company is driving a new era of innovation in healthcare IT.

As Pro Medicus (ASX: PME)continues to expand its footprint in North America, its focus on delivering scalable, efficient, and research-driven solutions positions it as a critical player in the global healthcare landscape.